Comorbidity: Substance Use Disorders and Other Psychiatric Conditions
合并症:药物使用障碍和其他精神疾病
基本信息
- 批准号:10617224
- 负责人:
- 金额:$ 32.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Abstract
Introduction: This is a renewal application for T32 institutional training grant application – Comorbidity:
Substance Use Disorders and Other Psychiatric Conditions (NIDA DA037183) -- following the completion of its
first five-year funding cycle. Among the current portfolio of NIDA funded training grants, only one program
other than ours (Dartmouth) has comorbidity as a primary focus. This is striking given co-occurrence
prevalence of Substance Use Disorders (SUD) with other psychiatric conditions and health conditions (e.g.
diabetes), and the extent to which either SUD or the comorbid disorder can go under- or untreated in
conventional treatment settings. The goals, elements and resources of the renewal program retains critical and
effective elements of the initial funding period while incorporating important lessons learned. Long term goals:
The proposed program will develop a cadre of scientists with research expertise in comorbidity mechanisms,
antecedents and correlates, diagnostics, and psychosocial and pharmacological interventions. Component
objectives are to provide each trainee with a working knowledge of comorbidity research including: (a)
translational science from Early Phase Clinical Trials to Community Based Participatory Research
perspectives; (b) effective research strategies for comorbid conditions across populations and ethnic and
cultural groups (e.g. American Indian, Hmong, Somali). Accomplishing programmatic features will capitalize on
(a) the spectrum of faculty expertise providing mentoring across multiple areas, and (b) integration across
training programs and departments. Key Elements: (1) Involvement of scientists and clinicians with diverse
expertise and a core internal advisory group. Primary sites (4 postdoctoral trainees, 2 yrs each) are the
Departments of Psychiatry and Psychology (UMN Twin Cities) and Family Medicine and Biobehavioral Health
(UMN Duluth); (2) Recruitment, including under represented group outreach, of rigorously screened PhD and
MD candidates with SUD and comorbidity as primary career focus; (3) Training with an interdisciplinary
mentoring team (primary & 2 secondary mentors) with complementary expertise; (4) Formal training plans with
clear milestones including trainee development of an NIH application initiated in Year 1; (5) Active research,
seminars, didactic course work, workshops, and development of management, ethics, and regulatory
expertise; (6) Dynamic program administration entailing monitoring with enhancements and problem resolution
along with continued contact with trainees after completion and; (7) Annually convened external advisory
group. Resources: Mentor funding sources include NIH Institutes, NSF, Minnesota Medical Foundation, and
pharmaceutical industry. Key Personnel and Primary Mentors are directors of clinics, centers, or departments
with significant resources.
摘要
项目成果
期刊论文数量(43)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Contribution of Antibody-Mediated Effector Functions to the Mechanism of Efficacy of Vaccines for Opioid Use Disorders.
- DOI:10.4049/jimmunol.2100204
- 发表时间:2021-08-01
- 期刊:
- 影响因子:0
- 作者:Huseby Kelcher AM;Baehr CA;Hamid FA;Hart GT;Pravetoni M
- 通讯作者:Pravetoni M
Global disruption in excitation-inhibition balance can cause localized network dysfunction and Schizophrenia-like context-integration deficits.
- DOI:10.1371/journal.pcbi.1008985
- 发表时间:2021-05
- 期刊:
- 影响因子:4.3
- 作者:Calvin OL;Redish AD
- 通讯作者:Redish AD
Conjoint adolescent developmental trajectories of alcohol and marijuana use and early adult outcomes among North American Indigenous people.
- DOI:10.1016/j.addbeh.2020.106758
- 发表时间:2021-03
- 期刊:
- 影响因子:4.4
- 作者:Sittner KJ;Hautala DS;Walls ML
- 通讯作者:Walls ML
Using a co-twin control design to evaluate alternative trait measures as indices of liability for substance use disorders.
- DOI:10.1016/j.ijpsycho.2019.11.012
- 发表时间:2020-02
- 期刊:
- 影响因子:3
- 作者:Joyner, Keanan J.;Yancey, James R.;Venables, Noah C.;Burwell, Scott J.;Iacono, William G.;Patrick, Christopher J.
- 通讯作者:Patrick, Christopher J.
Longitudinal Mechanisms Linking Perceived Racial Discrimination to Aggressive Delinquency among North American Indigenous Youth
- DOI:10.1177/0022427819834331
- 发表时间:2019-08-01
- 期刊:
- 影响因子:3.2
- 作者:Hautala, Dane;Sittner, Kelley
- 通讯作者:Sittner, Kelley
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MATT G KUSHNER其他文献
MATT G KUSHNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MATT G KUSHNER', 18)}}的其他基金
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
验证基于互联网的自主交互式交付经验支持的共病认知行为疗法
- 批准号:
10176912 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
验证基于互联网的自主交互式交付经验支持的共病认知行为疗法
- 批准号:
10597539 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
验证基于互联网的自主交互式交付经验支持的共病认知行为疗法
- 批准号:
10404961 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
拆解 CBT 治疗并发疾病的成分和剂量
- 批准号:
8716244 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
拆解 CBT 治疗并发疾病的成分和剂量
- 批准号:
9303851 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Comorbidity: Substance Use Disorders and Other Psychiatric Conditions
合并症:药物使用障碍和其他精神疾病
- 批准号:
9925206 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Dismantling the Components and Dosing of CBT for Co-Occurring Disorders
拆解 CBT 治疗并发疾病的成分和剂量
- 批准号:
9102860 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Comorbidity: Substance Use Disorders and Other Psychiatric Conditions
合并症:药物使用障碍和其他精神疾病
- 批准号:
10386930 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Comorbidity: Substance Use Disorders and Other Psychiatric Conditions
合并症:药物使用障碍和其他精神疾病
- 批准号:
10176435 - 财政年份:2014
- 资助金额:
$ 32.99万 - 项目类别:
Applying Latent Variable Modeling to Cormorbidity Treatment Research
将潜变量模型应用于疾病治疗研究
- 批准号:
8528426 - 财政年份:2009
- 资助金额:
$ 32.99万 - 项目类别:
相似海外基金
Multimodal profiling of microglia during HIV infection and substance use disorder
HIV 感染和物质使用障碍期间小胶质细胞的多模式分析
- 批准号:
10813965 - 财政年份:2023
- 资助金额:
$ 32.99万 - 项目类别:
Social determinants of substance use disorder treatment outcomes in a vulnerable population
弱势群体物质使用障碍治疗结果的社会决定因素
- 批准号:
10631031 - 财政年份:2022
- 资助金额:
$ 32.99万 - 项目类别:
Social determinants of substance use disorder treatment outcomes in a vulnerable population
弱势群体物质使用障碍治疗结果的社会决定因素
- 批准号:
10352689 - 财政年份:2022
- 资助金额:
$ 32.99万 - 项目类别:
Adult Progression of Adolescent Onset Substance Use Disorder in a High Risk Sample
高风险样本中青少年发作药物使用障碍的成人进展
- 批准号:
10389730 - 财政年份:2022
- 资助金额:
$ 32.99万 - 项目类别:
Adult Progression of Adolescent Onset Substance Use Disorder in a High Risk Sample
高风险样本中青少年发作药物使用障碍的成人进展
- 批准号:
10677547 - 财政年份:2022
- 资助金额:
$ 32.99万 - 项目类别:
Smart Steps: A context-aware adherence intervention to improve PrEP adherence among men who have sex with men (MSM) with substance use disorder
明智的步骤:情境感知的依从性干预措施可提高患有物质使用障碍的男男性行为者 (MSM) 的 PrEP 依从性
- 批准号:
10468388 - 财政年份:2022
- 资助金额:
$ 32.99万 - 项目类别:
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder
知识发现和机器学习阐明艾滋病毒活动及其与药物滥用障碍相互作用的机制
- 批准号:
10671033 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
A Mixed-Methods investigation of the implications of Substance Use Disorder Stigma for Justice-Involved Youth
混合方法调查药物使用障碍耻辱对参与正义的青少年的影响
- 批准号:
10313043 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
Knowledge discovery and machine learning to elucidate the mechanisms of HIV activity and interaction with substance use disorder
知识发现和机器学习阐明艾滋病毒活动及其与药物滥用障碍相互作用的机制
- 批准号:
10348407 - 财政年份:2021
- 资助金额:
$ 32.99万 - 项目类别:
Omics Analyses of HIV and Substance Use Disorder
HIV 和药物滥用障碍的组学分析
- 批准号:
10448502 - 财政年份:2019
- 资助金额:
$ 32.99万 - 项目类别: